Kelvin Chang

Mr. Kelvin Chang

orcid

Research Focus & Metrics

Representative Publications

View All Publications
19 August 2011 in Crystal Growth & Design
Verified
Journal Article
Closed access
MSMatthew D. Smith
Matthew D. Smith
SBSamuel M. Blau
Samuel M. Blau
KCKelvin Chang
Kelvin Chang
MZMatthias Zeller
Matthias Zeller
JSJoshua Schrier
Joshua Schrier
ANAlexander J. Norquist
Alexander J. Norquist

1 April 2016 in Journal of Solid State Chemistry
Verified
Journal Article
Closed access
KCKelvin Chang
Kelvin Chang
BEBryce W. Edwards
Bryce W. Edwards
LFLaszlo Frazer
Laszlo Frazer
ELErik J. Lenferink
Erik J. Lenferink
TSTeodor K. Stanev
Teodor K. Stanev
KPKenneth Poeppelmeier
Kenneth Poeppelmeier

5 July 2024 in The Journal of Physiology
Verified
Journal Article
Closed access
ABAlec Bizieff
Alec Bizieff
MCMaggie Cheng
Maggie Cheng
KCKelvin Chang
Kelvin Chang
HMHussein Mohammed
Hussein Mohammed
NZNaveed Ziari
Naveed Ziari
MHMarc K Hellerstein
Marc K Hellerstein

19 June 2026 in mAbs
Verified
Journal Article
Open access
SLSteffen Lippold
Steffen Lippold
KCKelvin Chang
Kelvin Chang
MDMirjam Dürkoop
Mirjam Dürkoop
JAJan Terje Andersen
Jan Terje Andersen
FYFeng Yang
Feng Yang
Tilman SchlothauerTilman Schlothauer
Tilman Schlothauer
The characterization of protein–protein interactions is fundamental to understanding the biological function and therapeutic efficacy of antibodies.1 Low-affinity protein–protein interactions (KD >...

17 October 2026 in Journal of Chromatography A
Verified
Journal Article
Closed access
SLSteffen Lippold
Steffen Lippold
SSSkanda Sastry
Skanda Sastry
KWKevin Whang
Kevin Whang
KCKelvin Chang
Kelvin Chang
MKMichael Kim
Michael Kim
TSTilman Schlothauer
Tilman Schlothauer

9 October 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KCKelvin Chang
Kelvin Chang
QCQinjingwen Cao
Qinjingwen Cao
CCChuntian Cai
Chuntian Cai
WCWayman Chan
Wayman Chan
ZHZhiqi Hao
Zhiqi Hao
FYFeng Yang
Feng Yang
Background/Objectives: The Multi-Attribute Method (MAM) uses LC-MS peptide mapping for targeted attribute quantitation (TAQ) and untargeted New Peak Detection (NPD) in product quality monitoring and quality control of biotherapeutics. As automated liquid handling systems are adopted, data demonstrating similar performance for both TAQ and NPD are essential to implement an automatic sample preparation workflow to fully achieve MAM capabilities. This study compares manual versus automated sample preparation workflows for both TAQ and NPD. Methods: Peptide mapping sample preparation was performed manually and on an automated liquid handling system. TAQ was evaluated using a reference monoclonal antibody (mAb1) while NPD was assessed by spiking a second monoclonal antibody (mAb2) into mAb1 (0.5–2% w/w relative abundance). NPD specificity and sensitivity were qualified using a product-specific peptide library, multiple bracketing comparisons, and a statistically derived Fold Change Detection (FCD) threshold. Results: For TAQ, the automated workflow demonstrated comparable performance to the manual method, with minimal quantitative differences and high reproducibility across 28 monitored product quality attributes. For NPD, all expected mAb2 peptides were detected with no false positives at each spike level. No new peaks were observed when comparing bracketing unspiked mAb1 samples, confirming specificity for NPD. Conclusions: The results demonstrate that automated sample preparation yields consistent TAQ and NPD data compared to manual methods and can be used for routine product quality monitoring.